Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 2/20 | 0.53 |
| ▸ | PRKCA | P17252 | 3/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | PAM | P19021 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL401286 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL526046 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL15751 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL43221 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685975 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2119135 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL119680 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL16041 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL62799 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL14696035 | 1.00 | LMNA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 36696 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144755-A1 | Solid Oral Dosage Forms Comprising Tavapadon | CEREVEL THERAPEUTICS, LLC (US) | 2026-05-28 | — | — | US | claimed |
| CN-122094690-A | Pharmaceutical composition comprising Maraglinib (MARALIXIBAT) and use thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122074696-A | Buccal product and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080093-A | Compounds effective in treating liver toxicity and fatty liver disease and uses thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026104110-A1 | FOAM CONDITIONER | HENKEL AG & CO. KGAA (DE) | 2026-05-21 | — | — | WO | claimed |
| US-20260137655-A1 | NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE | HK INNO.N CORPORATION (KR) | 2026-05-21 | — | — | US | claimed |
| WO-2026103205-A1 | ORALLY DISINTEGRATING TABLET OF PIMAVANSERIN OR SALT THEREOF AND PREPARATION METHOD THEREFOR | 江苏百奥信康医药科技有限公司 | 2026-05-21 | — | — | WO | claimed |
| WO-2026107172-A2 | ORAL COMPOSITIONS COMPRISING LP(A) INHIBITOR COMPOUNDS | ELI LILLY AND COMPANY (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122070135-A | Pharmaceutical compositions and methods of use thereof | 托特斯医药公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-1994027557-A2 | PHARMACEUTICAL THERMAL INFUSION PROCESS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| WO-1994006416-A1 | PHARMACEUTICAL TABLET CAPABLE OF LIBERATING ONE OR MORE DRUGS AT DIFFERENT RELEASE RATES | JAGOTEC AG (CH) | 1994-03-31 | — | — | WO | claimed |
| WO-1993018755-A1 | ALKYL-SUBSTITUTED CELLULOSE-BASED SUSTAINED-RELEASE ORAL DRUG DOSAGE FORMS | DEPOMED SYSTEMS, INCORPORATED (US) | 1993-09-30 | — | — | WO | claimed |
| EP-0487520-A4 | COMPRESSED POWDER MEDICAMENTS | — | 1992-08-12 | — | — | EP | claimed |
| US-5126145-A | Hydroxypropylmethyl cellulose, binder, hydrophobic component | TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK | 1992-06-30 | — | — | US | claimed |
| EP-0487520-A1 | COMPRESSED POWDER MEDICAMENTS. | ANESTA CORP (US) | 1992-06-03 | — | — | EP | claimed |
| WO-1991003099-A1 | COMPRESSED POWDER MEDICAMENTS | ANESTA CORPORATION (US) | 1991-03-07 | — | — | WO | claimed |
| US-4863737-A | TRANSMUCOSAL DELIVERY | UNIVERSITY OF UTAH (US) | 1989-09-05 | — | — | US | claimed |
| CN-87105828-A | The quick-acting compositionss of sulindac or sodium sulindac and alkali | — | 1988-04-27 | — | — | CN | claimed |
| EP-0259990-A1 | Rapid acting combination of sodium sulindac and a base | MERCK & CO. INC. (US) | 1988-03-16 | — | — | EP | claimed |